Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients

乳腺癌 肿瘤科 比例危险模型 接收机工作特性 内科学 癌症 Lasso(编程语言) 激素受体 化疗 生物 医学 万维网 计算机科学
作者
Jiaxiang Liu,Shuangtao Zhao,Chenxuan Yang,Li Ma,Qixi Wu,Xiangzhi Meng,Bo Zheng,Changyuan Guo,Kexin Feng,Qingyao Shang,Jiaqi Liu,Jie Wang,Jingbo Zhang,Guangyu Shan,Bing Xu,Yueping Liu,Jianming Ying,Xin Wang,Xiang Wang
出处
期刊:Chinese Medical Journal [Lippincott Williams & Wilkins]
卷期号:136 (2): 184-193 被引量:1
标识
DOI:10.1097/cm9.0000000000002411
摘要

Abstract Background: Breast cancer patients who are positive for hormone receptor typically exhibit a favorable prognosis. It is controversial whether chemotherapy is necessary for them after surgery. Our study aimed to establish a multigene model to predict the relapse of hormone receptor-positive early-stage Chinese breast cancer after surgery and direct individualized application of chemotherapy in breast cancer patients after surgery. Methods: In this study, differentially expressed genes (DEGs) were identified between relapse and nonrelapse breast cancer groups based on RNA sequencing. Gene set enrichment analysis (GSEA) was performed to identify potential relapse-relevant pathways. CIBERSORT and Microenvironment Cell Populations-counter algorithms were used to analyze immune infiltration. The least absolute shrinkage and selection operator (LASSO) regression, log-rank tests, and multiple Cox regression were performed to identify prognostic signatures. A predictive model was developed and validated based on Kaplan–Meier analysis, receiver operating characteristic curve (ROC). Results: A total of 234 out of 487 patients were enrolled in this study, and 1588 DEGs were identified between the relapse and nonrelapse groups. GSEA results showed that immune-related pathways were enriched in the nonrelapse group, whereas cell cycle- and metabolism-relevant pathways were enriched in the relapse group. A predictive model was developed using three genes ( CKMT1B , SMR3B , and OR11M1P ) generated from the LASSO regression. The model stratified breast cancer patients into high- and low-risk subgroups with significantly different prognostic statuses, and our model was independent of other clinical factors. Time-dependent ROC showed high predictive performance of the model. Conclusions: A multigene model was established from RNA-sequencing data to direct risk classification and predict relapse of hormone receptor-positive breast cancer in Chinese patients. Utilization of the model could provide individualized evaluation of chemotherapy after surgery for breast cancer patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
lx举报JACS的求助涉嫌违规
刚刚
小鞠佩奇完成签到,获得积分20
1秒前
思源的应助被花05采纳,获得10
1秒前
thyee完成签到,获得积分10
2秒前
2秒前
年糕发布了新的文献求助10
3秒前
5秒前
6秒前
6秒前
6秒前
chillax发布了新的文献求助30
6秒前
7秒前
SciGPT的应助被霁星河采纳,获得10
7秒前
周lm完成签到,获得积分10
8秒前
8秒前
Chw完成签到,获得积分10
8秒前
纯情的阁的应助被mmmm采纳,获得310
8秒前
9秒前
211107发布了新的文献求助10
10秒前
10秒前
chino发布了新的文献求助10
10秒前
70完成签到 ,获得积分10
10秒前
无极微光的应助被白三羽采纳,获得20
10秒前
molihuakai的应助被shuyiWang采纳,获得10
11秒前
11秒前
tong发布了新的文献求助10
12秒前
MKW完成签到,获得积分20
13秒前
haibo发布了新的文献求助10
13秒前
h11发布了新的文献求助10
13秒前
13秒前
20240901发布了新的文献求助10
13秒前
211107发布了新的文献求助10
14秒前
211107发布了新的文献求助10
14秒前
hhhh完成签到,获得积分20
14秒前
jingxia完成签到,获得积分10
15秒前
无极微光的应助被科研通管家采纳,获得20
15秒前
香蕉觅云的应助被科研通管家采纳,获得10
15秒前
共享精神的应助被科研通管家采纳,获得10
15秒前
大模型的应助被科研通管家采纳,获得30
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163664
求助须知:如何正确求助?哪些是违规求助? 9557817
关于积分的说明 21741980
捐赠科研通 7754358
什么是DOI,文献DOI怎么找? 3428338
关于科研通互助平台的介绍 2553000
邀请新用户注册赠送积分活动 2472943